NINDS awards Sinopia $3.3m for development of Parkinson’s drug candidate
Sinopia has been awarded a $3.3 million Fast-Track SBIR grant to fund the study for its small molecule candidate for Parkinson’s disease.
List view / Grid view
Sinopia has been awarded a $3.3 million Fast-Track SBIR grant to fund the study for its small molecule candidate for Parkinson’s disease.
An NIH team have built a cellular map of chronic multiple sclerosis (MS) lesions to identify cells that drive inflammation and potential therapies.
T cells may play an important role in Parkinson’s disease (PD), according to a new study...
8 June 2016 | By Victoria White, Digital Content Producer
Researchers have discovered that boosting the transport of mitochondria along neuronal axons enhances the ability of nerve cells to repair themselves...